Cannabinoids and Cancer Chemotherapy-Associated Adverse Effects is a research paper published in JNCI Monographs (2021). On theSindex it has a DataRank of 0. It has been cited 23 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R01AT010778-01
Analgesic efficacy of single and combined minor cannabinoids and terpenes
National Institutes of Health
Grant: 5P30DA033934-09
The Central Virginia Center on Drug Abuse Research
National Institutes of Health
Grant: 5R01DA039942-05
CB1 Allosteric Modulators: Molecular, Cellular and In Vivo Pharmacology
National Institutes of Health
Grant: 1R41DA044898-01
Development of KLS-13019 for Chemotherapy Induced Peripheral Neuropathy and Drug Dependence
National Institutes of Health
Grant: 5R01DA043571-05
Endocannabinoid Biosynthesis in Inflammation and Pain
NIDA NIH HHS
Grant: R01 DA039942
NIDA NIH HHS
Grant: P30 DA033934
NIDA NIH HHS
Grant: R01 DA043571
NIDA NIH HHS
Grant: R41 DA044898
NCCIH NIH HHS
Grant: R01 AT010778
FWCI
2.12
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals